Mehdi Yazdi the Art of API Method Development
Posted: October 12, 2018
Dr. Mehdi Yazdi Director of Analytical Services talks about the art of API method development at PCI Synthesis.
Related posts:
Generic Drug Makers Continue to Face Hurdles in Race to Make Drugs More Affordable
How to Stem the Flow of Tainted Generic Drugs and Product Recalls
The Role of Calibration in Ensuring Safe Measuring Instruments for API Manufacturing
Key Questions To Ask Your CMO About Their Analytical Capabilities
7 things to look for in a CMO’S CGMP Manufacturing Capabilities
About the Author
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...